Literature DB >> 7994898

Therapeutic advances in immunosuppression.

A W Thomson1, J V Forrester.   

Abstract

Immunosuppressive therapy is appropriate for the prevention or reversal of allograft rejection, and for the treatment of autoimmune disorders and allergic disease. Recent advances in our understanding of the cellular and molecular mechanisms that regulate immune responses have paralleled elucidation of the modes of action of a variety of therapeutic immunosuppressive agents, both 'old' and new. These developments have identified potential targets for more refined and specific intervention strategies that are now being tested in the clinic.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994898      PMCID: PMC1534501          DOI: 10.1111/j.1365-2249.1994.tb05496.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  64 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach.

Authors:  N Chand; J E Harrison; S Rooney; J Pillar; R Jakubicki; K Nolan; W Diamantis; R D Sofia
Journal:  Eur J Pharmacol       Date:  1992-01-28       Impact factor: 4.432

3.  Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen.

Authors:  M H Sayegh; Z J Zhang; W W Hancock; C A Kwok; C B Carpenter; H L Weiner
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

4.  Frequent achievement of a drug-free state after orthotopic liver transplantation.

Authors:  J Reyes; A Zeevi; H Ramos; A Tzakis; S Todo; A J Demetris; B Nour; M Nalesnik; M Trucco; K Abu-Elmagd
Journal:  Transplant Proc       Date:  1993-12       Impact factor: 1.066

Review 5.  Saying the 'S' word in public.

Authors:  D R Green; D R Webb
Journal:  Immunol Today       Date:  1993-11

Review 6.  Rapamycin: a novel immunosuppressive macrolide.

Authors:  S N Sehgal; K Molnar-Kimber; T D Ocain; B M Weichman
Journal:  Med Res Rev       Date:  1994-01       Impact factor: 12.944

7.  Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.

Authors:  C J Kuo; J Chung; D F Fiorentino; W M Flanagan; J Blenis; G R Crabtree
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

8.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

Authors:  L Chatenoud; E Thervet; J Primo; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 10.  Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.

Authors:  N H Sigal; F J Dumont
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

View more
  2 in total

1.  Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway.

Authors:  S Sharma; K Chopra; S K Kulkarni; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Effects of an immunosuppressive treatment on the rat prostate.

Authors:  Marta Grabowska; Karolina Kędzierska; Katarzyna Michałek; Sylwia Słuczanowska-Głąbowska; Maciej Grabowski; Małgorzata Piasecka; Andrzej Kram; Iwona Rotter; Aleksandra Rył; Maria Laszczyńska
Journal:  Drug Des Devel Ther       Date:  2016-09-12       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.